10 jelly-roll
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Organic oxygen compounds | 622 | 316.1 | 1.97× | q < 0.0001 | |
| Organic nitrogen compounds | 82 | 50.6 | 1.62× | q < 0.0001 | |
| Homogeneous metal compounds | 923 | 779.2 | 1.19× | q < 0.0001 | |
| Mixed metal/non-metal compounds | 33 | 33.3 | 0.99× | q = 1.00 | |
| Organic acids and derivatives | 234 | 245.6 | 0.95× | q = 0.52 | |
| Homogeneous non-metal compounds | 299 | 341.7 | 0.88× | q = 0.01 | |
| Alkaloids and derivatives | 4 | 5.4 | 0.74× | q = 0.88 | |
| Organosulfur compounds | 24 | 32.7 | 0.73× | q = 0.18 | |
| Benzenoids | 71 | 116.1 | 0.61× | q < 0.0001 | |
| Organoheterocyclic compounds | 135 | 244.3 | 0.55× | q < 0.0001 | |
| Lipids and lipid-like molecules | 94 | 176.8 | 0.53× | q < 0.0001 | |
| Phenylpropanoids and polyketides | 15 | 33.0 | 0.45× | q = 1.6e-3 | |
| Hydrocarbons | 3 | 11.1 | 0.27× | q = 0.02 | |
| Nucleosides, nucleotides, and analogues | 116 | 438.8 | 0.26× | q < 0.0001 | |
| Lignans, neolignans and related compounds | 2 | 1.2 | 1.69× | not tested | |
| Miscellaneous inorganic compounds | 1 | 1.2 | 0.84× | not tested | |
| Organic 1,3-dipolar compounds | 1 | 1.3 | 0.75× | not tested | |
| Hydrocarbon derivatives | 1 | 1.4 | 0.73× | not tested | |
| Organohalogen compounds | 2 | 4.5 | 0.44× | not tested | |
| Organometallic compounds | 1 | 2.3 | 0.44× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00141 | NAG | N-Acetylglucosamine | 3,264 |
| DB08845 | AKG | Oxogluric acid | 511 |
| DB00150 | TRP | Tryptophan | 456 |
| DB03721 | SIA | N-acetyl-alpha-neuraminic acid | 276 |
| DB02527 | CMP | Cyclic adenosine monophosphate | 273 |
| DB02315 | PCG | Cyclic GMP | 129 |
| DB00139 | SIN | Succinic acid | 113 |
| DB02379 | BGC | Beta-D-Glucose | 81 |
| DB08231 | MYR | Myristic acid | 80 |
| DB03796 | PLM | Palmitic Acid | 77 |
| DB01979 | MMA | Methyl alpha-D-mannoside | 54 |
| DB03567 | A2G | alpha-N-Acetyl-D-galactosamine | 54 |
| DB03103 | TYD | Thymidine-5'- Diphosphate | 51 |
| DB04473 | FUC | alpha-L-fucose | 51 |
| DB03345 | BME | Mercaptoethanol | 48 |
| DB02831 | 2HP | Dihydrogenphosphate | 42 |
| DB00171 | ATP | ATP | 39 |
| DB16881 | 88E | E-52862 | 36 |
| DB00125 | ARG | Arginine | 33 |
| DB01862 | IPT | Isopropyl beta-D-thiogalactopyranoside | 33 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| NAG | 2-acetamido-2-deoxy-beta-D-glucopyranose | 4,269 |
| CAmetal | CALCIUM ION | 3,766 |
| MNmetal | MANGANESE (II) ION | 1,355 |
| CL | CHLORIDE ION | 1,222 |
| MGmetal | MAGNESIUM ION | 1,136 |
| ZNmetal | ZINC ION | 932 |
| NAmetal | SODIUM ION | 856 |
| NImetal | NICKEL (II) ION | 783 |
| FEmetal | FE (III) ION | 533 |
| AUmetal | GOLD ION | 528 |
| AKG | 2-OXOGLUTARIC ACID | 501 |
| OGA | N-OXALYLGLYCINE | 487 |
| TRP | TRYPTOPHAN | 456 |
| FE2metal | FE (II) ION | 406 |
| GAL | beta-D-galactopyranose | 314 |
| CMP | ADENOSINE-3',5'-CYCLIC-MONOPHOSPHATE | 288 |
| SIA | N-acetyl-alpha-neuraminic acid | 187 |
| Kmetal | POTASSIUM ION | 175 |
| CUmetal | COPPER (II) ION | 146 |
| COmetal | COBALT (II) ION | 134 |